Medgend Icon







discontinued


Axid FDA Approved Drugs

AXID AR [NizatidineC12H21N5O2S2]
OTC
-
75mg (oral tablet)
PfizerMay 9, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEXAMETHASONE [DexamethasoneC22H29FO5]
RX
-
0.5mg (oral tablet)
0.5mg/5ml (oral elixir)
0.75mg (oral tablet)
1.5mg (oral tablet)
1mg (oral tablet)
2mg (oral tablet)
4mg (oral tablet)
6mg (oral tablet)
Par PharmApr 28, 1983
West-ward Pharms IntApproved Prior To Jan 1, 1982
LyneJul 12, 2011
Sti Pharma LlcApproved Prior To Jan 1, 1982
Vintage PharmsMay 11, 2011
Wockhardt Eu OperatnJul 27, 1983
EcrAug 15, 2008
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEXAMETHASONE INTENSOL [DexamethasoneC22H29FO5]
RX
-
1mg/ml (oral concentrate)
West-ward Pharms IntSep 1, 1983
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEXAMETHASONE SODIUM PHOSPHATE [Dexamethasone Sodium PhosphateC22H28FO8P2Na]
RX
-
eq 0.1% phosphate (ophthalmic, otic solution/drops)
eq 10mg phosphate/ml (injection injectable)
eq 4mg phosphate/ml (injection injectable)
Bausch And LombJul 26, 1996
Sandoz IncJan 16, 1985
Fresenius Kabi UsaApr 22, 2005
Mylan Labs LtdAug 29, 2008
West-ward Pharms IntSep 7, 1982
Aurobindo Pharma LtdDec 1, 2015
LuitpoldJul 21, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE [Dexamethasone Sodium PhosphateC22H28FO8P2Na]
RX
-
eq 10mg phosphate/ml (injection injectable)
Fresenius Kabi UsaApr 11, 2003
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

GATIFLOXACIN [Gatifloxacin2C19H22FN3O43H2O]
RX
-
0.5% (ophthalmic solution/drops)
Hi-tech Pharma CoSep 3, 2014
Lupin LtdAug 28, 2013
Sandoz IncJul 11, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MAXIDEX [DexamethasoneC22H29FO5]
RX
-
0.1% (ophthalmic suspension/drops)
Novartis Pharms CorpApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NIZATIDINE [NizatidineC12H21N5O2S2]
RX
-
150mg (oral capsule)
15mg/ml (oral solution)
300mg (oral capsule)
Ani Pharms IncSep 12, 2002
Dr Reddys Labs LtdSep 15, 2005
Glenmark GenericsJul 15, 2011
Mylan Pharms IncJul 5, 2002
SandozJul 5, 2002
Watson LabsJul 9, 2002
Amneal PharmsNov 18, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OZURDEX [DexamethasoneC22H29FO5]
RX
-
0.7mg (intravitreal implant)
AllerganJun 17, 2009
  • Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex.
  • Intravitreal treatment of diabetic macular edema.
  • Intravitreal treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).
  • Treatment of macular edema.
  • Treatment of uveitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZYMAR [Gatifloxacin2C19H22FN3O43H2O]
RX
-
0.3% (ophthalmic solution/drops)
AllerganMar 28, 2003
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZYMAXID [Gatifloxacin2C19H22FN3O43H2O]
RX
-
0.5% (ophthalmic solution/drops)
AllerganMay 18, 2010
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.